Seroatlas · Human Serome Atlas

NCLN

BOS complex subunit NCLN

Also known as: NCLN_HUMAN, NET59, NICALIN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q969V3
Gene
NCLN
Ensembl
ENSG00000125912
Chromosome
19
Canonical length
563 aa
Protein class
Predicted intracellular proteins, Predicted membrane proteins, Transporters
Subcellular location
Nucleoplasm,Lipid droplets

OverviewNCBI Gene

Enables ribosome binding activity. Involved in several processes, including multi-pass transmembrane protein insertion into ER membrane; protein stabilization; and regulation of protein complex stability. Located in endoplasmic reticulum membrane. Part of multi-pass translocon complex. [provided by Alliance of Genome Resources, Jul 2025]

Canonical amino-acid sequenceUniProt

563 residues, UniProt reviewed canonical sequence.

>Q969V3|NCLN
     1  MLEEAGEVLE NMLKASCLPL GFIVFLPAVL LLVAPPLPAA DAAHEFTVYR MQQYDLQGQP
    61  YGTRNAVLNT EARTMAAEVL SRRCVLMRLL DFSYEQYQKA LRQSAGAVVI ILPRAMAAVP
   121  QDVVRQFMEI EPEMLAMETA VPVYFAVEDE ALLSIYKQTQ AASASQGSAS AAEVLLRTAT
   181  ANGFQMVTSG VQSKAVSDWL IASVEGRLTG LGGEDLPTIV IVAHYDAFGV APWLSLGADS
   241  NGSGVSVLLE LARLFSRLYT YKRTHAAYNL LFFASGGGKF NYQGTKRWLE DNLDHTDSSL
   301  LQDNVAFVLC LDTVGRGSSL HLHVSKPPRE GTLQHAFLRE LETVAAHQFP EVRFSMVHKR
   361  INLAEDVLAW EHERFAIRRL PAFTLSHLES HRDGQRSSIM DVRSRVDSKT LTRNTRIIAE
   421  ALTRVIYNLT EKGTPPDMPV FTEQMQIQQE QLDSVMDWLT NQPRAAQLVD KDSTFLSTLE
   481  HHLSRYLKDV KQHHVKADKR DPEFVFYDQL KQVMNAYRVK PAVFDLLLAV GIAAYLGMAY
   541  VAVQHFSLLY KTVQRLLVKA KTQ

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against NCLN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Other membrane
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.26
Highest tissue expression
60 nTPM

Expression across tissuesHPA

Tissue

  • adrenal gland: 60 nTPM
  • liver: 55 nTPM
  • pancreas: 52 nTPM
  • spleen: 41 nTPM
  • cerebellum: 39 nTPM
  • colon: 35 nTPM

Single-cell type

  • late spermatids: 82 nCPM
  • alveolar cells type 1: 79 nCPM
  • colonocytes: 78 nCPM
  • enterocytes: 75 nCPM
  • enteric transient amplifying cells: 72 nCPM
  • extravillous trophoblasts: 65 nCPM

Immune cell

  • plasmacytoid DC: 19 nTPM
  • classical monocyte: 13 nTPM
  • intermediate monocyte: 13 nTPM
  • eosinophil: 9.8 nTPM
  • total PBMC: 9.6 nTPM
  • myeloid DC: 9.2 nTPM

Brain region

  • hippocampal formation: 40 nTPM
  • cerebral cortex: 39 nTPM
  • thalamus: 39 nTPM
  • medulla oblongata: 36 nTPM
  • amygdala: 35 nTPM
  • midbrain: 34 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about NCLN.

Disease | GeneticClinVar

1 pathogenic / likely-pathogenic of 108 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.4
gnomAD pLI
0.76
gnomAD missense Z
1.66
DepMap mean gene effect
-0.05
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of NCLN in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads NCLN as an antibody target. Whether an autoantibody or antibody against NCLN could matter depends on whether native NCLN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

NCLN is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label NCLN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/NCLN. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...